Sterling Pharma Solutions

Sector:

A specialised provider of Active Pharmaceutical Ingredient (‘API’) development and manufacturing services to the global biopharmaceutical industry

United Kingdom,US

Business Overview

  • Sterling is a specialised provider of Active Pharmaceutical Ingredient (‘API’) development and manufacturing services to the global biopharmaceutical industry. The company focuses on small molecules that are particularly complex and difficult to manufacture
  • The company delivers a full-service offering of API development and GMP manufacturing to support its customers throughout the entire product lifecycle. Its complex proprietary technologies and processes support Sterling’s capability to provide services from clinical development, through market launch to commercial supply
  • Sterling is one of few players globally with expertise in the handling and production of complex APIs, an area which is demonstrating strong market growth. This is supported by a fully compliant manufacturing site in the UK with a strong track record with global regulators including the FDA and EMA
  • Sterling has a diverse customer base ranging from emerging drug development companies to midsized and specialist pharmaceutical companies, as well as established long-standing relationships with large, market-leading pharmaceutical companies, including five of the top ten global leaders

Investment Thesis

  • Leading specialized API manufacturer with complex chemistry capabilities servicing the full molecule lifecycle and resulting in high barriers to entry
  • High recurring repeat business and excellent customer retention
  • Longstanding and diversified blue chip customer base, including five of the top ten pharmaceutical companies globally
  • Attractive and growing Contract Drug Manufacturing Organisations (CDMO) market underpinned by favourable macroeconomic trends
  • Experienced sponsor with a specialist focus on healthcare, significant knowledge of the CDMO market and a track record of driving international growth to create leading global businesses